title: Live-donor renal transplantation at the Urology & Nephrology Center of Mansoura: 1976-1998.
abstract: Based on more than 1,200 living donor transplants performed at the Urology & Nephrology Center at Mansoura University between 1976-1998, we report: 1. The overall graft survival rate was 75.8% and 51.9% at 5 and 10 years, respectively, with a projected half-life of 10.7 years. 2. Three factors acted as independent variables that significantly influenced graft survival: the number of HLA mismatches, the number of acute rejection episodes and the presence of posttransplant hypertension. a. Grafts with 2 or fewer HLA-A, -B and -DR mismatches had a significantly better survival rate. b. The incidence and the number of early acute rejection episodes had a significant negative impact on graft survival. c. A significant reduction in graft survival was associated with hypertension uncontrolled by or newly developed after transplantation. 3. Bilharziasis had no impact on the outcome. 4. Despite improvements in tissue matching and immunosuppression, an important proportion of grafts is still lost following living-donor kidney transplantation. 5. Efforts must be directed to identify better regimens, which can provide adequate immunosuppression and minimal nephrotoxicity.
authors.affiliation: Department of Urology, Division of Nephrology, Division of Clinical Immunology, Urology & Nephrology Center, Mansoura, Egypt.
authors.forename: M A
authors.initials: MA
authors.lastname: Ghoneim
authors.forename: M A
authors.initials: MA
authors.lastname: Bakr
authors.forename: N
authors.initials: N
authors.lastname: Hassan
authors.forename: I
authors.initials: I
authors.lastname: Wahba
authors.forename: A S
authors.initials: AS
authors.lastname: Fouda
authors.forename: M A
authors.initials: MA
authors.lastname: Sobh
authors.forename: A B
authors.initials: AB
authors.lastname: Shehab el-Dein
authors.forename: A A
authors.initials: AA
authors.lastname: Shokeir
authors.forename: M M
authors.initials: MM
authors.lastname: el-Mekresh
authors.forename: B
authors.initials: B
authors.lastname: Ali-el-Dein
authors.forename: Y M
authors.initials: YM
authors.lastname: Osman
authors.forename: A
authors.initials: A
authors.lastname: Moustafa
authors.forename: F
authors.initials: F
authors.lastname: el-Chenawi
mesh_terms: D000046:Academic Medical Centers; D000328:Adult; D004534:Egypt; D005260:Female; D006084:Graft Rejection / Q000209:etiology; D006085:Graft Survival; D006648:Histocompatibility; D006748:Hospital Departments; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000209:etiology; D016030:Kidney Transplantation / Q000009:adverse effects / Q000276:immunology; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D009398:Nephrology; D014572:Urology